These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24867676)
1. αKlotho and vascular calcification: an evolving paradigm. Hu MC; Kuro-o M; Moe OW Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):331-9. PubMed ID: 24867676 [TBL] [Abstract][Full Text] [Related]
2. αKlotho and Chronic Kidney Disease. Neyra JA; Hu MC Vitam Horm; 2016; 101():257-310. PubMed ID: 27125746 [TBL] [Abstract][Full Text] [Related]
3. Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy. Law JP; Price AM; Pickup L; Radhakrishnan A; Weston C; Jones AM; McGettrick HM; Chua W; Steeds RP; Fabritz L; Kirchhof P; Pavlovic D; Townend JN; Ferro CJ J Am Heart Assoc; 2020 Apr; 9(7):e016041. PubMed ID: 32212912 [TBL] [Abstract][Full Text] [Related]
4. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein). Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790 [TBL] [Abstract][Full Text] [Related]
5. The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Barker SL; Pastor J; Carranza D; Quiñones H; Griffith C; Goetz R; Mohammadi M; Ye J; Zhang J; Hu MC; Kuro-o M; Moe OW; Sidhu SS Nephrol Dial Transplant; 2015 Feb; 30(2):223-33. PubMed ID: 25324355 [TBL] [Abstract][Full Text] [Related]
6. Role of Uremic Toxins in Early Vascular Ageing and Calcification. Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534 [TBL] [Abstract][Full Text] [Related]
7. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2. Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772 [TBL] [Abstract][Full Text] [Related]
8. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. Kitagawa M; Sugiyama H; Morinaga H; Inoue T; Takiue K; Ogawa A; Yamanari T; Kikumoto Y; Uchida HA; Kitamura S; Maeshima Y; Nakamura K; Ito H; Makino H PLoS One; 2013; 8(2):e56695. PubMed ID: 23431388 [TBL] [Abstract][Full Text] [Related]
9. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats. de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365 [TBL] [Abstract][Full Text] [Related]
10. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635 [TBL] [Abstract][Full Text] [Related]
11. The role of klotho on vascular calcification and endothelial function in chronic kidney disease. Vervloet MG; Adema AY; Larsson TE; Massy ZA Semin Nephrol; 2014 Nov; 34(6):578-85. PubMed ID: 25498377 [TBL] [Abstract][Full Text] [Related]
12. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960 [TBL] [Abstract][Full Text] [Related]
14. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease. Xu M; Li H; Bai Y; He J; Chen R; An N; Li Y; Dong Y Am J Med Sci; 2021 May; 361(5):624-634. PubMed ID: 33781552 [TBL] [Abstract][Full Text] [Related]
15. CDC42 promotes vascular calcification in chronic kidney disease. Li Z; Wu J; Zhang X; Ou C; Zhong X; Chen Y; Lu L; Liu H; Li Y; Liu X; Wu B; Wang Y; Yang P; Yan J; Chen M J Pathol; 2019 Dec; 249(4):461-471. PubMed ID: 31397884 [TBL] [Abstract][Full Text] [Related]
16. Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Agapova OA; Fang Y; Sugatani T; Seifert ME; Hruska KA Kidney Int; 2016 Jun; 89(6):1231-43. PubMed ID: 27165838 [TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification. Chao CT; Liu YP; Su SF; Yeh HY; Chen HY; Lee PJ; Chen WJ; Lee YM; Huang JW; Chiang CK; Hung KY; Chen HW Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1402-1414. PubMed ID: 28522697 [TBL] [Abstract][Full Text] [Related]
18. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification. Hou YC; Lu CL; Zheng CM; Chen RM; Lin YF; Liu WC; Yen TH; Chen R; Lu KC Nutrients; 2019 Jan; 11(1):. PubMed ID: 30642029 [TBL] [Abstract][Full Text] [Related]